About Vibalogics
Vibalogics is a Healthcare company based in Cuxhaven (Germany) founded in 2007, and was acquired by Recipharm in February 2022. CDMO offering development, cGMP manufacturing and fillfinish of biologics based on viruses and bacteria. Vibalogics offers products and services including RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Microbial Strains. Its legal entity is Recipharm AB.
Company details
Vibalogics is a CDMO offering development, cGMP manufacturing and fillfinish of products based on viruses and bacteria for companies involved in the development of vaccines, gene and oncolytic viral therapies in the biopharmaceutical industry. Vibalogics is capable of all carrying out all activities for clinical drug development right from feasibility assessment to product release for companies committed to developing therapeutic prophylactic vaccines and biological products, based on viruses, live bacteria and aseptic processing. Their manufacturing facility is GMP compliant, BSL-2 classified and has been inspected and approved by European regulatory agencies. Vibalogics is part of the consortium lead by JJ and funded by IMI (Innovative Medicines Initiative) for Ebola Vaccine development.
- Headquarters Cuxhaven, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vibalogics.com
- Social LinkedIn X YouTube
- Acquired by Ampersand Capital (May 2019)
- Legal Name Recipharm Ab
Products & Services of Vibalogics
Vibalogics offers a comprehensive portfolio of products and services, including RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing.
Service for producing RNA therapies and related components
Process for manufacturing plasmid DNA for therapeutic use
Development and production of viral vectors for medical applications
Apps and channels of Vibalogics
its YouTube channel Recipharm CDMO has 308 subscribers and 30 videos.
Videos from Vibalogics
The most watched videos on Vibalogics's YouTube channel, Recipharm CDMO (308 subscribers). Click a video to play it here.
More on Recipharm CDMO.
Funding Insights of Vibalogics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Vibalogics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2015 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Vibalogics
Vibalogics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Recipharm, Innovative Health Initiative and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States | ||
Health research and innovation are funded through public-private partnerships. | 2021 | imi.europa.eu | Brussels, Belgium | |
Pharmaceutical development and manufacturing services are offered contractually. | 1995 | recipharm.com | Jordbro, Sweden |
Investor details for Vibalogics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vibalogics
4 dated milestones of Vibalogics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Vibalogics is founded.
- Funding First funding round.
- Exit Acquired by Ampersand Capital.
- Exit Acquired by Recipharm.
Web traffic of Vibalogics
Websites that share an audience with Vibalogics (vibalogics.com).
Websites whose visitors overlap most with Vibalogics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| almacgroup.com | 100% | 63.1K | #547,621 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vibalogics
Complete news archive for Vibalogics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vibalogics
Vibalogics was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Vibalogics is headquartered in Cuxhaven, Germany. It is registered at Cuxhaven, Lower Saxony, Germany.
Vibalogics is a CDMO offering development, cGMP manufacturing and fillfinish of products based on viruses and bacteria for companies involved in the development of vaccines, gene and oncolytic viral therapies in the biopharmaceutical industry. Vibalogics is capable of all carrying out all activities for clinical drug development right from feasibility assessment to product release for companies committed to developing therapeutic prophylactic vaccines and biological products, based on viruses, live bacteria and aseptic processing. Their manufacturing facility is GMP compliant, BSL-2 classified and has been inspected and approved by European regulatory agencies. Vibalogics is part of the consortium lead by JJ and funded by IMI (Innovative Medicines Initiative) for Ebola Vaccine development.
Vibalogics offers RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing.
Vibalogics has 3 investors. Key investors include Recipharm, Innovative Health Initiative, and Ampersand Capital Partners.
Vibalogics operates through Recipharm Ab.
Yes. Vibalogics was acquired by Ampersand Capital in May 2019.